Alithea Biotechnology GmbH
PrivateLast Round
Seed
Jun 23, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alithea Biotechnology GmbH is a biotechnology company that provides immunopeptidomics research services, AI-driven target discovery, and a proprietary HLA peptide database to support the development of precision immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alithea Biotechnology GmbH Comparables
Compare Alithea Biotechnology GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pure MHC, LLC | 78% | |
| Bruker | 71% | |
| ProImmune Ltd | 69% | |
Alithea Biotechnology GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 23, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 220% MoM, reaching 1.6K.
- Jun 22, 2026
Monthly visitors increased 61% MoM.
Alithea Biotechnology GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alithea Biotechnology GmbH's valuation, stock price, and market status.